Endovenous laser ablation of the great saphenous vein — duplex mapping, tumescent protection, fiber pullback, and thermal vein closure
Varicose veins are the visible surface expression of a deeper hemodynamic failure: incompetent one-way valves in the superficial venous system allow blood to flow backward under gravity instead of returning to the heart. The great saphenous vein (GSV), running from the ankle to the groin along the medial thigh and leg, is the most common site of this reflux. Duplex ultrasound — combining B-mode anatomical imaging with Doppler flow measurement — is the diagnostic gold standard, allowing a sonographer to watch blood flow reverse in real time and to map exactly which segment of vein needs to be treated.
Veins in the leg work against gravity, relying on two mechanisms to return blood to the heart: the calf muscle pump, which squeezes deep veins during walking, and one-way bicuspid valves spaced every few centimeters along superficial and perforating veins, which prevent backward flow between muscle contractions.
When valve leaflets fail to coapt — due to congenital weakness, hormonal effects on vein wall collagen, prolonged standing, obesity, or prior deep vein thrombosis — blood pools and refluxes downward with each release of the calf pump. This retrograde column of blood raises ambulatory venous pressure in the lower leg, a state called venous hypertension. Chronically elevated pressure dilates the vein further, which stretches adjacent valves and worsens their coaptation, creating a self-perpetuating cycle. Over years this progresses from cosmetic varicosities and aching to edema, skin pigmentation (hemosiderin deposition), lipodermatosclerosis, and ultimately venous stasis ulceration in the most advanced (CEAP C6) cases.
The diagnostic study is performed with the patient standing, since venous reflux is gravity-dependent and largely collapses when supine. The sonographer identifies the saphenofemoral junction, then scans the GSV distally in transverse and longitudinal planes, recording diameter at multiple levels and applying manual calf compression-release maneuvers (or a Valsalva maneuver at the SFJ) while the Doppler gate is open over the vein segment.
Normal valves close within milliseconds of the reverse pressure gradient. Retrograde flow lasting longer than 0.5 seconds after augmentation is the accepted diagnostic threshold for pathologic reflux. The exam documents the proximal and distal extent of the incompetent segment, its diameter along its course, tortuosity, and the status of the saphenofemoral and saphenopopliteal junctions — all of which determine whether the patient is a candidate for endovenous thermal ablation and exactly how much vein length needs treatment.
A GSV with reflux duration of 1–2 seconds and a mid-thigh diameter of 6–9 mm sitting just below a competent SFJ valve is the classic, most favorable anatomy for endovenous laser ablation.
Before any energy is delivered, two planning steps determine the safety and effectiveness of the ablation: precise measurement of GSV diameter along the treatment length, and infiltration of tumescent anesthesia — a large volume of dilute local anesthetic — around the entire perivenous sheath under ultrasound guidance. Tumescent fluid is not merely for pain control; it performs three simultaneous jobs that make endovenous ablation both tolerable and safe.
For most of the 20th century, incompetent saphenous veins were treated by high ligation and stripping — surgically tying off the SFJ and physically pulling the vein out through the leg. Stripping is effective at eliminating reflux but requires general or spinal anesthesia, produces bruising and pain along the entire stripped tract, carries a measurable risk of saphenous nerve injury (numbness), and keeps patients out of normal activity for one to two weeks.
Endovenous laser ablation (EVLA), introduced in the early 2000s alongside radiofrequency ablation, achieves an equivalent or better closure rate through a single ultrasound-guided needle puncture, under local tumescent anesthesia alone, in an office-based procedure lasting well under an hour. Patients walk out and typically resume normal activity within a day. Randomized trials comparing EVLA to stripping have shown faster recovery, less postoperative pain and bruising, and closure rates at one year that meet or exceed surgical stripping — which is why thermal ablation has become the first-line treatment in most modern venous guidelines, with stripping reserved for anatomy unsuitable for catheter access.
Tumescent solution is infiltrated as a series of small injections along the full length of vein to be treated, guided continuously by ultrasound so the sonographer can watch the fluid spread as a dark (anechoic) halo encircling the bright vein sheath. It performs three distinct functions at once:
1. Analgesia: dilute lidocaine (typically 0.1%, far below concentrations used for regional blocks) numbs the perivenous tissue and skin, making an awake, walk-in-walk-out procedure comfortable without systemic sedation.
2. Mechanical compression: the fluid volume physically compresses the vein down around the laser fiber, reducing the vein's cross-sectional diameter and blood volume in the lumen. A smaller, blood-emptied lumen means laser energy is absorbed more efficiently by the vein wall itself rather than being wasted heating a column of blood, and it presses the wall into close, even contact with the fiber tip circumferentially.
3. Thermal heat sink and protection: the fluid layer acts as an insulating buffer that limits the spread of heat outward from the vein wall, protecting the skin, saphenous nerve, and surrounding subcutaneous tissue from thermal injury. Without an adequate tumescent cuff, the same energy that reliably closes the vein could instead cause skin burns or nerve paresthesia.
A minimum tumescent cuff of roughly 1 cm circumferentially around the vein, confirmed by ultrasound before firing the laser, is the accepted safety threshold — thinner cuffs increase the risk of skin thermal injury and post-procedure paresthesia.
Getting the laser fiber to exactly the right position is as important as the energy settings used to fire it. Percutaneous access, sheath placement, and fiber tip localization are all performed under continuous real-time ultrasound guidance, culminating in a fiber tip resting a carefully measured 2 cm below the saphenofemoral junction — close enough to treat all refluxing vein, far enough to avoid injuring the deep femoral vein.
The procedure begins with the patient supine, leg externally rotated, and the treatment segment prepped under sterile technique. Using real-time ultrasound, the operator identifies the GSV lumen in transverse view and advances a micropuncture needle directly into the vein — typically at or near the knee, or at the most distal point of documented reflux. A guidewire is passed through the needle, the needle exchanged for a vascular sheath over the wire (the Seldinger technique), and the sheath advanced cephalad under ultrasound until its tip approaches the SFJ.
The laser fiber is then threaded through the sheath and advanced the remaining distance, with the sonographer tracking the bright, echogenic fiber tip in longitudinal view the entire way. Correct fiber position is confirmed in two planes before any energy is delivered — this single verification step is one of the most important safety checks in the entire procedure.
The saphenofemoral junction is where the superficial GSV drains into the deep femoral vein — the boundary between a vessel that can safely be thermally destroyed and one that must never be touched by ablative energy, since occluding a deep vein risks a proximal deep vein thrombosis and pulmonary embolism.
Placing the fiber tip roughly 2 cm distal to the SFJ (sometimes referenced from the takeoff of the superficial epigastric vein or another tributary) leaves enough treated vein length to eliminate reflux at the junction, while keeping the zone of thermal injury safely clear of the femoral vein itself. Too close, and heat or thrombus can propagate into the deep system; too far, and a stump of untreated refluxing GSV is left behind, which is a recognized cause of clinical recurrence. This 2 cm rule is one of the most consistently cited technical parameters across endovenous ablation guidelines worldwide.
Final fiber tip position is always re-confirmed by ultrasound immediately before activating the laser — position drifts easily during tumescent infiltration, and a few millimeters of error at the SFJ has outsized clinical consequences.
With the fiber positioned and tumescent anesthesia infiltrated along the full treatment length, the laser is activated and the fiber withdrawn at a controlled, steady rate — continuously or in rapid pulses — while a console tracks the energy delivered per unit length of vein: the linear endovenous energy density, or LEED, expressed in joules per centimeter (J/cm). Getting this dose right, matched to the vein's diameter, is the single biggest determinant of whether the vein closes permanently or recanalizes.
The laser fiber tip converts optical energy into heat at the vein wall, either by direct absorption in intraluminal blood and hemoglobin (older 810–980 nm wavelengths) or by absorption in the water content of the vein wall itself (newer 1320–1470 nm wavelengths, which tend to cause more uniform wall heating with less bruising). As wall temperature rises above roughly 60–100°C, collagen fibers in the tunica media denature and contract, the endothelial lining is destroyed, and the vein wall shrinks circumferentially around a collapsing lumen. Over the following weeks, the thermally injured vein is replaced by fibrous scar tissue, converting a once-patent refluxing channel into a solid, non-conducting cord.
Too little heat leaves patches of viable endothelium and incompletely contracted wall, which can reopen (recanalize) as the acute thrombus organizes and remodels. Too much heat over-treats the vein with little added closure benefit while increasing pain, bruising, and the risk of thermal injury to the perivenous tissue if the tumescent cuff is inadequate.
LEED is calculated directly from console settings: laser power output (watts) multiplied by activation time (seconds), divided by the length of vein treated (centimeters) — equivalently, power divided by pullback speed. A console typically displays LEED in real time as the operator withdraws the fiber, allowing continuous adjustment of pullback speed to hit the planned target.
Because a wider vein has more wall surface area and blood volume to heat, larger-diameter segments require proportionally higher LEED to achieve the same depth and completeness of wall injury as a narrow segment. Consensus practice broadly targets 60–100 J/cm along most of the GSV, with larger veins (approaching 10–12 mm) treated at the upper end of this range or with slower, more deliberate pullback, and smaller veins requiring less energy to avoid over-treatment. Automated mechanical pullback devices, which withdraw the fiber at a constant, operator-set speed, produce more reproducible LEED delivery along the entire treated segment than manual hand withdrawal.
LEED (J/cm) = Laser Power (W) × Activation Time (s) ÷ Treated Length (cm). Most protocols target roughly 60–100 J/cm, scaled upward for wider veins, with published data showing closure rates fall sharply once delivered LEED drops below about 50–60 J/cm for a mid-sized GSV.
The procedure's success is not declared at the moment the fiber is withdrawn — it is confirmed days and months later by repeat duplex ultrasound, which must show a non-compressible, non-flowing, thrombosed vein along the entire treated segment. Symptom relief typically follows quickly, but the durability of closure over time, and vigilance for the minority of veins that recanalize, define long-term success.
1. Standing duplex ultrasound maps the refluxing GSV segment and confirms reflux duration >0.5 s. 2. GSV diameter is measured at multiple levels; the treatment plan and tumescent volume are estimated. 3. Percutaneous ultrasound-guided access is obtained and a sheath is advanced cephalad. 4. The laser fiber is threaded to a position 2 cm below the saphenofemoral junction and confirmed in two planes. 5. Tumescent anesthesia is infiltrated along the entire treatment length under ultrasound, achieving a full perivenous cuff. 6. The laser is activated and the fiber withdrawn at a controlled rate, delivering the planned LEED continuously along the segment. 7. Compression stocking is applied immediately; the patient is encouraged to walk right away to reduce DVT risk. 8. Follow-up duplex at roughly one week confirms occlusion and screens for endovenous heat-induced thrombosis extending into the deep system. 9. Longer-term surveillance (months to years) monitors for segmental recanalization or new reflux in tributary veins.
A successfully ablated GSV appears on follow-up duplex as a thickened, echogenic (bright) cord with no measurable lumen, no color flow signal on Doppler, and no compressibility under probe pressure — the opposite of a normal patent vein, which is anechoic (dark) and fully compressible. Over the following months this cord typically shrinks further and may become difficult to identify at all as fibrosis matures.
Blood that previously refluxed through the incompetent superficial system is now carried entirely by the competent deep venous system and the calf muscle pump, restoring a more normal, unidirectional pattern of venous return. Clinically, patients report resolution of aching, heaviness, and evening leg swelling within days to a few weeks, and visible improvement of associated varicosities and skin changes over subsequent months as venous pressure normalizes.
Not every treated segment stays permanently closed. A minority of veins — reported in roughly 5–15% of cases over several years of follow-up — undergo partial or complete recanalization, most often at the proximal stump near the SFJ or in segments that received a lower-than-target LEED, for example where a tortuous vein caused the fiber to advance unevenly or where tumescent compression was suboptimal.
Recanalization does not always cause symptoms; many small recanalized channels remain hemodynamically insignificant. When reflux does return with a recanalized segment, options include repeat thermal ablation, ultrasound-guided foam sclerotherapy of the reopened channel, or, rarely, surgical intervention. This is why venous societies recommend structured duplex surveillance after ablation rather than treating the initial closure scan as the final word — the true measure of success is durable occlusion over years, not just at the one-week check.
The strongest predictor of durable closure identified across EVLA outcome studies is adequate LEED delivered evenly along the entire treated length — segments that received less than the target energy density are disproportionately represented among later recanalizations.